This is default featured slide 1 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 2 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 3 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 4 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 5 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

Your shampoo may be cleaning your hair, but is it treating your scalp?

Most shampoos do a decent job of cleaning the hair shaft. But if you keep dealing with flakes, an itchy scalp, or that persistent oily feeling, the problem likely isn't your hair. It's what's happening underneath.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gGRMwAE
via IFTTT

Apollo Hospitals taps Shobana Kamineni to chair soon-to-be listed Healthtech unit

Apollo Hospitals is appointing Shobana Kamineni as executive chairperson of its upcoming medical equipment business, Apollo Healthtech. This move is part of a larger restructuring plan to unlock business value. Apollo Healthtech is expected to be listed separately. The company aims for significant revenue by listing. This signals a focus on growth and governance for the new entity.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0Rbf8iQ
via IFTTT

Novartis India launches Pluvicto for prostate cancer treatment

Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision radiotherapy precisely targets cancer cells, offering a new treatment approach for metastatic prostate cancer. The therapy will be available through select hospitals and nuclear medicine centers across India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/f1EnHrB
via IFTTT

India known as nation with world's largest healthcare programme: PM Modi

Prime Minister Narendra Modi said India has made healthcare more affordable and accessible over the past 12 years through initiatives such as Ayushman Bharat and the PM Bharatiya Jan Aushadhi Pariyojana. He highlighted lower-cost medicines and medical devices, expanded medical education, and progress in tackling diseases like tuberculosis.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/b0K2LuN
via IFTTT

Maharashtra FDA bars hospitals from forcing patients to buy medicines in-house

Maharashtra's Food and Drug Administration has issued a significant directive. Hospitals and medical practitioners must now allow patients to purchase medicines from any licensed pharmacy. Patients will receive their prescriptions directly. This move aims to prevent unfair trade practices and protect patient consumer rights.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/htfYjdp
via IFTTT

Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriers

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While offering potential benefits, experts highlight concerns about its high cost and the need for early diagnosis. The drug's real-world impact in India remains a subject of discussion among neurologists and the company.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Mp3YCOg
via IFTTT

India raises price cap on cancer drugs to tackle shortage

India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused by a sharp rise in platinum costs. The National Pharmaceutical Pricing Authority (NPPA) approved the one-time hike in public interest after supply disruptions affected hospitals across the country.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fkU3Y9y
via IFTTT